The Biology of Peroxiredoxin 6
The Biology of Peroxiredoxin 6
批准号:
10686366
负责人:
Jose P Vazquez Medina
金额:
$37.68万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-07-31
关键词:
Acute Lung InjuryAcylationAcyltransferaseAffectAntioxidantsApplications GrantsBiochemical PathwayBiological AssayBiologyCatalytic DomainCell DeathCell RespirationCell membraneCellsCentral Nervous System DiseasesChronicCystineDataDegenerative DisorderDiseaseEnzymesEquilibriumFutureGene Expression ProfileHomeostasisHydrogen PeroxideHypoxiaImaging TechniquesInflammationIronIschemiaLysophosphatidylcholinesMaintenanceMale InfertilityMediatorMitochondriaMorphologyMusMuscular AtrophyNon-Insulin-Dependent Diabetes MellitusOxidation-ReductionPathway interactionsPhospholipase A2PhospholipidsPhysiologicalPoint MutationPrevention strategyProteinsRegulationReperfusion InjuryRespirationRetinal DiseasesRoleStrokeThree-Dimensional ImagingTraumatic Brain Injuryanalytical toolcarcinogenesiscell growth regulationextracellularglutathione peroxidaseinterestmitochondrial metabolismnoveloxygen toxicityperoxiredoxinrepair enzymetranslational approachuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Peroxiredoxin 6 (Prdx6) is a multi-functional enzyme that expresses glutathione peroxidase, phospholipase A2
(PLA2), and lysophosphatidylcholine acyltransferase (LPCAT) activities in separate catalytic sites. Prdx6 can
reduce phospholipid hydroperoxides and hydrolyze and re-acylate phospholipid fatty acyl bonds. Prdx6 is,
therefore, a complete enzyme for the repair of peroxidized cell membranes. Prdx6 has been implicated in
several pathophysiological conditions, including acute lung injury, inflammation, carcinogenesis, various
chronic central nervous system diseases, retinal disease, type 2 diabetes, muscle atrophy, and male infertility,
but basic questions about the biology of this unique enzyme remain unanswered. Our preliminary data strongly
suggest that Prdx6 suppresses ferroptosis, an iron-dependent form of regulated cell death driven by the
accumulation of phospholipid hydroperoxides. Emerging evidence implicates ferroptosis in several
degenerative diseases, carcinogenesis, stroke, traumatic brain injury, and ischemia/reperfusion injury, among
others. Hence, establishing the mechanisms and physiological relevance of ferroptosis regulation by Prdx6 is
crucial. My lab is interested in studying the role of the glutathione peroxidase, PLA2, and LPCAT activities of
Prdx6 on the regulation of ferroptosis induced by inhibition of cystine uptake, hypoxia/reoxygenation, and
oxygen toxicity. We will use mice and cells with single point mutations that inactivate each of the activities of
Prdx6 without affecting the others, along with state-of-the-art analytical tools to dissect the role of this enzyme
on the regulation of ferroptosis. In a second project, I propose to study the role of Prdx6 in the maintenance of
mitochondrial function. Our preliminary data show that Prdx6 deficiency alters transcriptional signatures of
mitochondrial metabolism and reduces mitochondrial respiration. We will study the effects of the catalytic
activities of Prdx6 on mitochondrial morphology, dynamics, and function using extracellular flux assays and
three-dimensional imaging techniques. The results of this proposal will contribute to our understanding of one
of the critical mediators of cellular redox balance. These results will also provide essential information for future
translational strategies for the prevention and treatment of diseases associated with dysregulated redox
homeostasis.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
The role of lysophosphatidic acid signaling in lung ischemia/reperfusion injury
-
批准号:9070355
-
项目类别:
-
资助金额:$5.8万
-
财政年份:2015
-
负责人:Jose P Vazquez Medina
-
依托单位:
海外基金